|
|
||
| |
Terms and Topics
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
-
Cerapedics Closes $15 Million Series B Financing
New Capital to Fund OUS Sales Growth and Ongoing Clinical Trials of Its i-FACTOR Peptide Enhanced Bone Graft Platform for Spine, Trauma and Orthopedic Applications WESTMINSTER, Colo. Cerapedics, Inc., a privately held medical device company focused on developing and commercializing novel osteobiologic products based on its proprietary small peptide attachment factor technology platform, recently completed a round of private equity financing totaling $15 million. NGN Capital led the round and was joined by sole Series A […]April 6th, 2009 No comments
Read the rest of this entry » -
Centice Corporation Closes $4 Million Bridge Financing
Funds to Support Commercialization of Innovative PASS Rx Product MORRISVILLE, N.C. Centice Corporation, a pioneer in drug verification and safety products, announced today the successful completion of a $4 million bridge financing from its existing investors to support ongoing commercialization efforts for its innovative PASS Rx prescription verification product for the retail pharmacy marketplace. Leading […]April 6th, 2009 No comments
Read the rest of this entry » -
Socialcast Announces Series A Venture Funding from True Ventures, Angels
$1.4 Million Investment Complemented by Board Addition of Om Malik SAN FRANCISCO Socialcast, a leading provider of on demand social business communication software, today announced it has secured $1 million in Series A venture capital funding from True Ventures (www.trueventures.com). The investment will help Socialcast meet growing demand for its private online communities that companies use to quickly and easily share questions and ideas, find information and resources, and collaborate […]April 6th, 2009 No comments
Read the rest of this entry » -
SEPATON Secures $15.5 Million Funding Round Led by Focus Ventures
Investment validates enterprise-class, market-leading data protection solution provider MARLBOROUGH, Mass. SEPATON, Inc., the leader in enterprise-class VTL and data duplication solutions, today announced that it has closed a new round of funding, securing $15.5 million in series F financing. New investor Focus Ventures led the round while existing investors, Jerusalem Venture Partners (JVP), Menlo Ventures, Valhalla Partners, and HarbourVest […]April 6th, 2009 No comments
Read the rest of this entry » -
RevolutionCard Now Accepted at Barnes & Noble, Bloomingdales, CVS, Nordstrom, Whole Foods and Thousands of Other Retail Locations Revolutionary Payments Platform Continues to Grow in Challenging Economy ST. PETERSBURG, Fla. Revolution Money, the payments company backed by Steve Case’s Revolution LLC, today announced it has received $42 million in Series C funding from a Goldman Sachs affiliate (a new investor), as well as AOL co-founder Case, […]
April 6th, 2009 No comments
Read the rest of this entry » -
Northern Light Venture Capital Announces Promotion of Investing Professionals
Elton Jiang Named Managing Director; Lixin Li Promoted to Venture Partner MENLO PARK, Calif. and BEIJING, April 6 Northern Light Venture Capital (“NLVC”), a leading China focused venture capital firm, today announced the promotion of two investing professionals based in China. Reflective of the firm’s commitment to growing its China footprint and their contributions to the company, Elton Jiang was promoted to Managing Director and Lixin Li to Venture Partner. “Northern Light congratulates Elton and Lixin in their newly expanded roles,” said Feng Deng, Managing Director of NLVC. “We look forward to their valuable contributions as partners in […]April 6th, 2009 No comments
Read the rest of this entry » -
Infusion of Capital and Expansion of Leadership Team Position LSI to Revolutionize Power for Consumer Electronic Devices WILMINGTON, Mass., April 2 Lilliputian Systems, Inc. (www.lilliputiansystemsinc.com), developer of the world’s first Personal Power(TM) solution for consumer electronic (CE) devices, today announced the closing of an additional $28M in financing, the addition of Ray Stata to its Board of Directors and the appointment of Michael Umana as EVP and CFO. Lilliputian Systems announced that it has secured an additional $28 million in venture funding. Joining its current investors, which include Kleiner Perkins Caufield Byers of Menlo Park, CA (www.kpcb.com), Atlas Venture of Waltham MA (www.atlasventure.com), Fairhaven […]
April 2nd, 2009 No comments
Read the rest of this entry » -
Traversa Therapeutics Completes Series B Financing
Company Continues to Advance toward the Clinic with Novel RNA Interference Technologies LA JOLLA, Calif. Traversa Therapeutics, a preclinical-stage biopharmaceutical company developing novel RNA interference (RNAi) technologies, announced today the successful completion of its Series B financing, raising $5 million. The financing was led by Morningside Venture Investments Ltd., and joined by Mesa Verde Venture Partners and existing investors. Proceeds from the investment will support the advancement of Traversa’s […]April 2nd, 2009 No comments
Read the rest of this entry » -
eToro Closes $6.3 Million Round of Financing
Company to Support Platform Extension and Product Development LONDON, April 1 eToro, the fastest growing online financial trading platform, today announced it closed a $6.3 million round of financing with significant investments made by several private equity and VC investors including BRM Group and Cubit Investments. The online financial trading company which began as a unique and innovative online forex trading (http://www.etoro.com) platform has achieved all of its original investor goals leading to the successful second round of financing. With an average of 2,000 new accounts opened every month, eToro is growing its staff at a time when most companies are reducing headcount. “eToro has […]April 1st, 2009 No comments
Read the rest of this entry » -
Growth capital to drive further adoption of companys Health EarningsTM System, which helps employers control health care costs and employees earn rewards through healthier behaviors MINNEAPOLIS RedBrick Health, the Health EarningsTM company, announced today that it has secured $15 million in Series C financing. New investor Kleiner Perkins Caufield & Byers (KPCB) led the round of financing, which also included participation from existing investors Highland Capital Partners, […]
April 1st, 2009 No comments
Read the rest of this entry » -
Venture Capital Investment in Renewable Energy Exceeds $836.1M in Q1 2009
Greentech Media Reports Solar as the Dominant Sector, While Investment Hits 2007 Levels But Remains Encouraging CAMBRIDGE, Mass. Greentech Media Inc., the industry-leading online media company covering green technology news and analysis, released the most recent quarterly data showing that venture capital investment in green technologies totaled $836.1 million in 59 deals in the first quarter of 2009. The numbers are approximately back to 2007 levels. Ira Ehrenpreis, General Partner at greentech investment firm, Technology […]April 1st, 2009 No comments
Read the rest of this entry » -
AirSage Closes $2.5M Financing Round
Funding Will Be Used to Expand Sales Efforts and Enhance Product Pipeline ATLANTA AirSage, the world leader in patented technology which turns real-time cell phone signals into meaningful location, movement and traffic data, announced it has recently closed a $2.5 million financing round. The majority of investors for this round were angel investors from Switzerland and the United States. The company will use this investment round to expand its sales efforts […]March 31st, 2009 No comments
Read the rest of this entry » -
Announces Hiring of CTO – Former Dir. of Engineering at Cyberonics and CSO – Former Chief Scientist at Advanced Bionics DALLAS MicroTransponder Inc., a privately held medical device company, announced today that it has closed a $2.2M Series A round of funding, which brings the total investment to over $4.85M in the last 11 months. MicroTransponder is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological […]
March 31st, 2009 No comments
Read the rest of this entry » -
VantagePoint Venture Partners Adds Two Experienced Partners to CleanTech Practice
SAN BRUNO, Calif., March 31 VantagePoint Venture Partners today announced that Brad Mattson, an accomplished CEO, engineer and entrepreneur, and Mark Platshon, an experienced CEO and CleanTech investor, have joined the Firm as Partners in its leading CleanTech practice. “I am extremely pleased to welcome Brad and Mark to our team,” said Alan Salzman, CEO and Managing Partner of VantagePoint. “Each has a proven track record of successful entrepreneurship and the demonstrated ability to commercialize transformative technologies. They share our vision of investing in 21st century technologies to develop the leading companies of the new energy economy that can tackle our […]March 31st, 2009 No comments
Read the rest of this entry » -
SAN JOSE, Calif. Greetz, the online personalised, printed and posted greeting card service has attracted new capital for further growth. ePlanet Ventures together with existing shareholder Prime Technology Ventures have jointly invested substantial new capital in the company. With this capital Greetz can strengthen its position in the Dutch market and realise its international ambition, to become the market leader in […]
March 30th, 2009 No comments
Read the rest of this entry » -
Charles River Ventures Closes Fourteenth Fund at $320 Million
CRP XIV Will Focus on Early-Stage Information Technology Investment Opportunities WALTHAM, Mass. and MENLO PARK, Calif. (March 30, 2009) – Charles River Ventures (CRV), one of the nation’s leading early-stage venture capital firms, today announced that it has closed its fourteenth fund, CRP XIV, at $320 million. The closing of CRP XIV brings the firm’s total capital under management to approximately $2.1 billion. “Over the last two years, we’ve worked with talented entrepreneurs to achieve more than a dozen positive exits across our portfolio, including three […]March 30th, 2009 No comments
Read the rest of this entry » -
PHILADELPHIA BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania, today announced a $550,000 seed-stage investment in Novira Therapeutics, Inc., an emerging life sciences company in Southeastern Pennsylvania. Novira is focused on the discovery and development of first-in-class antiviral therapeutics. Based on emerging biology and proprietary insights on virus-host interactions, the company is working to develop novel small molecule drugs against medically-important viral […]
March 30th, 2009 No comments
Read the rest of this entry » -
Aushon BioSystems Raises $6.5 Million in New Round of Financing
Companys strong performance and strategic vision for future growth in pre-clinical and clinical biomarker research spurs continued financial support BILLERICA, Mass. Aushon BioSystems, Inc., the leading provider of advanced microarray instrumentation and laboratory services for biomarker analysis, recently announced that it has received additional financing of $6.5 million. The financing was led exclusively by North Bridge Venture Partners. The financing was used, in part, to support Aushon’s recent purchase of the SearchLight® Protein Array business and […]March 30th, 2009 No comments
Read the rest of this entry » -
New Class of Solid State Storage Devices Provides Unparalleled I/O Performance, Reliability and Green Advantages for Data Centers and High-Performance Computing MILPITAS, Calif., March 30 Pliant Technology, developer of Enterprise Flash Drives (EFDs), a new class of high-performance solid state storage devices for the enterprise, today announced that it has received $15 million in Series C funding. Pliant’s EFDs are designed to deliver dramatically higher levels of I/O performance while meeting the growing need for increased energy efficiency and reliability in enterprise computing environments. Pliant plans to use the Series C funding as working capital to support the volume production ramp-up of its […]
March 30th, 2009 No comments
Read the rest of this entry » -
Pathway Medical Technologies Secures $40 Million Financing
New Funding Round Positions Pathway for Profitability KIRKLAND, Wash. Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), today announced that it has successfully secured a $40 million Series D round of financing. This new round of funding includes participation from Forbion Capital Partners, HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Giza Venture Capital and […]March 30th, 2009 No comments
Read the rest of this entry » -
Livescribe Raises $18.6MM Funding in Q1 2009
Additional $7.5MM Raised Accelerates Growth Plans OAKLAND, Calif. Livescribe Inc. (www.livescribe.com) announced today the closing of its Series B funding of $7.5 million by Aeris Capital, a private Switzerland-based investment company. Livescribe also secured $11.1 million in its Series A round last month led by Vantage Point Ventures Partners and Lionhart Investments Ltd., raising a total of $18.6 million in funding within the first quarter of […]March 30th, 2009 No comments
Read the rest of this entry » -
EL SEGUNDO, Calif. Ripple TV, a digital place-based television company that operates a national network of screens in specialty retail locations, announced today that the company has raised $4 million in venture capital funding from Draper Fisher Jurvetson and Trinity Ventures. Ripple TV’s network of digital screens delivers national news, entertainment and sports content along with regional and local information such as weather, […]
March 26th, 2009 No comments
Read the rest of this entry » -
Lifefactory Inc., Makers of BPA Free Baby Bottles, Announces Initial Round of Venture Financing
Seed Round Led By Greenhouse Capital Partners LP Raises $750,000 SAUSALITO, Calif. Lifefactory Inc. (formerly known as Babylife), a design and manufacturing firm of green consumer products for adults and infants including BPA free baby bottles, today announced it has completed its $750,000 initial funding round. The seed financing was led by Greenhouse Capital Partners LP, a seed and early stage venture capital firm specializing in cleantech investments and innovations. […]March 26th, 2009 No comments
Read the rest of this entry » -
Visible Measures Raises $10 Million in Series C Financing
Latest Funding Positions Firm for Further Growth BOSTON, March 26 Visible Measures, the independent third-party measurement firm for Internet video publishers, advertisers, and viral marketers, announced today that it has secured a Series C round of financing of $10 million, led by new investor Northgate Capital with participation from existing investors General Catalyst Partners and MDV-Mohr Davidow Ventures. Visible Measures has raised over $29 million in total financing to date. This new financing will help solidify Visible Measures’ market position as the third-party measurement provider of choice for the Internet video industry’s leading advertisers, publishers, and aggregators. “We are incredibly fortunate to be […]March 26th, 2009 No comments
Read the rest of this entry » -
Audience Closes $15 Million Round of Funding
Financial support demonstrates confidence in Audience’s business plan MOUNTAIN VIEW, Calif., March 25 Audience today announced it raised $15 million in Series D funding in February, bringing the total funding amount to date to $60 million. Demonstrating confidence in the company’s ability to capitalize on its leadership position in a new emerging market, existing investors funded the round. Investors include New Enterprise Associates (NEA), Tallwood Venture Capital, Vulcan Capital and VentureTech Alliance. “With its deployments by major handset manufacturers and superior technology, Audience is clearly the leader in advanced noise suppression for mobile handsets,” said Forest Baskett, General Partner at NEA. “We believe […]March 25th, 2009 No comments
Read the rest of this entry » -
Sofinnova Partners Voted 2008 "European Venture Capital Firm of the Year"
– Private Equity International Award recognizes Sofinnova’s investment leadership in promising start-ups; 2009 off to strong start in portfolio company M&A PARIS, March 24 Sofinnova Partners (http://www.sofinnova.fr), a Paris-based venture capital firm, announced today that it has been awarded the 2008 “European Venture Capital Firm of the Year” by the publication Private Equity International (PEI) and its on-line version, Private Equity Online (PEO). The award recognizes Sofinnova’s investment expertise and leadership in Western Europe’s technology and life sciences industries throughout 2008. “We are thrilled to be recognized for our solid investment style during these turbulent economic times,” said Jean Schmitt, managing partner at […]March 25th, 2009 No comments
Read the rest of this entry » -
Western Association of Venture Capitalists Hosts VC Legends Roundtable to Examine Investment in Todays Business Climate and the Future of Venture Capital MENLO PARK, Calif. The Western Association of Venture Capitalists (WAVC) will host a VC Legends Roundtable for the venture capital community on Wednesday, April 15th at the newly-opened Rosewood Sand Hill Hotel in Menlo Park. Sequoia Capital’s Michael Moritz will moderate a discussion with six of the venture capital industry’s earliest pioneers—men who […]
March 25th, 2009 No comments
Read the rest of this entry » -
LeisureLink Announces $6.2 Million Venture Round
Rapid Growth During Recession Drives Investment PASADENA, Calif. LeisureLink, Inc, the leading distribution and revenue management platform for specialty lodging suppliers, today announced that it has closed the first tranche of a $6.2 million equity investment round. The investment was led by Mission Ventures and Clearstone Venture Partners, with additional participation from other insiders. “LeisureLink has dramatically grown revenues in spite of the difficult economic environment, and we believe this is […]March 25th, 2009 No comments
Read the rest of this entry » -
CoolIT Systems Closes $6.2 Million Financing
Capital Plan Supports Mainstream Performance-Computing Adoption of Liquid Cooling CALGARY, Canada CoolIT Systems, the industry leader in advanced electronics cooling solutions, has completed a CDN $6.2M financing package. The investment was led by iNovia Capital, a leading venture capital fund manager, and included existing angel investors and AVAC Ltd. CoolIT recently launched its breakthrough Domino Advanced Liquid Cooling (ALC) solution for desktop computers to industry acclaim at the Consumer Electronics Show […]March 24th, 2009 No comments
Read the rest of this entry » -
Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
NEW BRUNSWICK, N.J., March 23 Each year in the United States more than 138,000 people are diagnosed with leukemia, lymphoma or myeloma. These new cases account for 10 percent of the new total cancer cases in the U.S. per year. For several types of leukemia, the survival rate has not changed in the past 25 years. That’s why James M. Golubieski, president of Foundation Venture Capital Group, LLC, a New Jersey Health Foundation affiliate, is proud to announce that the company has made a $500,000 commitment to Actinobac Biomed Inc., a company developing a therapeutic agent targeting white leukemic blood cells for […]March 23rd, 2009 No comments
Read the rest of this entry »
NEWS: